Rivastigmine is Associated with Restoration of Left Frontal Brain Activity in Parkinson’s Disease

OBJECTIVE: To investigate how acetylcholinesterase inhibitor (ChEI) treatment impacts brain function in Parkinson’s disease (PD). METHODS: Twelve patients with PD and either dementia or mild cognitive impairment underwent task-free functional magnetic resonance imaging before and after three months...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Possin, Katherine L., Kang, Gail A., Guo, Christine, Fine, Eric M., Trujillo, Andrew J., Racine, Caroline A., Wilheim, Reva, Johnson, Erica T., Witt, Jennifer L., Seeley, William W., Miller, Bruce L., Kramer, Joel H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4001926/
https://ncbi.nlm.nih.gov/pubmed/23847120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25575
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg